Sigma-Aldrich Launches Online STAIN EXPERT™ Application
News Sep 08, 2005
Sigma-Aldrich has launched the STAIN EXPERT, a web-based application developed to assist customers with the retrieval of stain and dye information.
Located on the Sigma-Aldrich Hematology and Histology web page, the STAIN EXPERT is designed to provide an intuitive interface for navigating staining procedures, catalog information, product specifications, Material Safety Data Sheets, Certificates of Analysis and technical bulletins.
A Flash Platform is designed to guide customers through a wide range of staining procedures while reducing the complexity of multi-step processes.
Reagent preparation and staining results are extensively covered and the integration of the Sigma-Aldrich web search engine with recommended chemicals ensures that customers can quickly and easily find what they are looking for.
"This application provides an engaging and innovative user experience for retrieving stain-related content," commented Mark Frei, Technical Marketing Specialist at Sigma-Aldrich, "and offers a dynamic online experience worth returning to."
Researchers Awarded $28M for Illuminating Druggable Genome NIH GrantsNews
Researchers receive grants as part of the NIH program focused on experimental and informatics approaches to characterize understudied proteins from three gene families: ion channels, G protein-coupled receptors (GPCRs), and protein kinases.READ MORE
No Country for Old GenesNews
Our modern world is radically different from the one we evolved in, and that creates a mismatch between the environment our genes were evolved to face, and the world those genes now encounter. A new review looks at how certain genes that benefited humans in our genetic past now predispose us to disease in old age.READ MORE
CRISPR Editing Stops HIV Virus in Infected CellsNews
Human immunodeficiency virus-1 (HIV-1) infection is a chronic disease affecting more than 35 million people worldwide. The infection can be controlled by antiretroviral therapy (ART), but there is still no complete cure. Now, a new study targeting the regulatory genes of the virus using CRISPR/Cas9 has helped block the production of the virus by infected cells.READ MORE